News Conference News EuroPCR 2025 Meta-analysis Quashes Hopes for Routine Embolic Protection in TAVI Michael O'Riordan May 21, 2025
News Conference News European Congress on Obesity 2025 SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly Michael O'Riordan May 14, 2025
News Daily News Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention Michael O'Riordan May 07, 2025
News Daily News Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact Yael L. Maxwell May 05, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2025 Caitlin E. Cox April 30, 2025
News Daily News Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE Caitlin E. Cox April 23, 2025
News Daily News High-Sensitivity Troponin Tests Might Aid in Primary Prevention Yael L. Maxwell April 16, 2025
News Conference News ACC 2025 RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI Michael O'Riordan April 02, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2025 Caitlin E. Cox April 01, 2025
News Conference News ACC 2025 Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection Michael O'Riordan March 30, 2025
News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Daily News Risk of Another Event Remains High for Years After TIA, Minor Stroke Todd Neale March 26, 2025
News Daily News Cannabis Use Again Tied to Increased CVD Risk in Young People L.A. McKeown March 19, 2025
News Daily News Newer Weight-Loss Drugs Not Cost-effective at Current Prices Michael O'Riordan March 18, 2025
News Daily News Better Cardiovascular Health May Stave Off Degenerative Brain Disease Todd Neale March 13, 2025
News Daily News Patient-Centric Outcomes Embraced by Global Heart Valve Experts L.A. McKeown February 24, 2025
News Daily News ‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials Michael O'Riordan February 20, 2025